Is Septerna, Inc. (SEPN) Stock a Biotech Opportunity With a Potential First-in-Class Hypoparathyroidism Treatment?
In another operational update, Septerna, Inc.
Septerna Inc. (SEPN)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 6,995,858 | $168,110,468 | 1.78% | |
| 2. | Driehaus Capital Richard Driehaus | 4,395,572 | $105,625,595 | -9% | 0.78% |
| 3. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 3,149,128 | $75,673,546 | 7.35% | |
| 4. | Siren L.L.C. Raymond Debbane | 2,000,000 | $48,060,000 | 1.33% | |
| 5. | Biotechnology Value Fund / BVF Inc Mark Lampert | 1,353,249 | $32,518,573 | -22% | 1.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.93 | 13,319 | $92,270.04 | 117,420 | 2025-03-07 | Filing | |
| $6.00 | 41,355 | $248,130.00 | 104,101 | 2025-03-06 | Filing | |
| $5.82 | 37,835 | $220,260.24 | 62,746 | 2025-03-05 | Filing | |
| $6.35 | 7,491 | $47,543.88 | 24,911 | 2025-03-04 | Filing | |
| $5.80 | 3,000 | $17,400.00 | 771,907 | 2025-02-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.99 | 4,000 | $135,974.00 | 174,209 | 2026-07-15 | Filing | |
| $34.81 | 1,233 | $42,925.79 | 96,412 | 2026-07-01 | Filing | |
| $34.10 | 2,100 | $71,602.44 | 97,645 | 2026-07-01 | Filing | |
| $35.18 | 2,178 | $76,622.04 | 793 | 2026-06-29 | Filing | |
| $35.97 | 7,000 | $251,780.90 | 96,412 | 2026-06-22 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,119 | $37,475 | 0% | |
| 2. | 261 | $8,741 | 0% | |
| 3. | 104 | $3,483 | 0% | |
| 4. | 20 | $670 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
8 Best Up and Coming Pharmaceutical Stocks to Buy Now
Investors looking for substantial potential without making a sizable initial investment continue to be drawn to inexpensive stocks.
10 Best Rebound Stocks To Invest In Now
The United States economy is in a constant state of flux.
Hedge Fund Resource Center